Dramatic reduction in prescribing of hepatitis C antivirals may leave many curable patients untreated
Direct-acting antivirals (DAAs) can cure hepatitis C (HCV) in more than 95% of individuals treated. But only 1 in 3 people with HCV in the U.S. receive treatment […]




